Minocycline inhibits neuronal death and glial activation induced by β-amyloid peptide in rat hippocampus

GLIA

Volumn 48, Issue 1, 2004, Pages 85-90

  Ryu, Jae K ^a   Franciosi, Sonia ^a   Sattayaprasert, Prasongchai ^a   Kim, Seung U ^a,b   McLarnon, James G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Ajou University   (South Korea)

Author keywords

amyloid peptide; Alzheimer's disease; Astrocytes; Cyclooxygenase 2; Hippocampus; Microglia; Minocycline; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CYCLOOXYGENASE 2; MINOCYCLINE; ANTIINFECTIVE AGENT; ISOENZYME; NEUROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; GLIA CELL; GLIOSIS; GRANULE CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INJECTION; MICROGLIA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ASTROCYTE; BIOSYNTHESIS; CELL DEATH; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GLIA; MALE; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTROCYTES; CELL DEATH; CYCLOOXYGENASE 2; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MINOCYCLINE; NERVE DEGENERATION; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 6044273035     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20051     Document Type: Article

References (24)

1. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD. 1994. Activation of a novel microglial gene encoding a lysosomal membrane protein in response to neuronal apoptosis. J Neurosci Res 38:365-375.
2. Benveniste EN, Nguyen VT, O'Keefe GM. 2001. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem Int 39:381-391.
3. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB. 2001. In-vivo measurement of activated microglia in dementia. Lancet 358:461-467.
4. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM. 2000. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797-801.
5. Combs CK, Karlo JC, Kao SC, Landreth GE. 2001. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179-1188.
6. Coraci IS, Husemann J, Berman JW, Hulette C, Dufour JH, Campanella GK, Luster AD, Silverstein SC, El-Khoury JB. 2002. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol 160:101-112.
7. Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE. 1998. Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle" in disease progression. Brain Pathol 8:65-72.
8. Ho L, Pieroni C, Winger D, Purohit DP, Aisen PS, Pasinetti GM. 1999. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J Neurosci Res 57:295-303.
9. Jantaratnotai N, Ryu JK, Kim SU, McLarnon JG. 2003. Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo. NeuroReport 14:1429-1433.
10. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, Brachova L, Van SD, Walker DG, Shen Y, Rogers J. 2001. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35:72-79.
11. Mackenzie IR, Munoz DG. 1998. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50: 986-990.
12. McGeer PL, McGeer EG. 2001. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22:799-809.
13. O'Callaghan JP, Jensen KF, Miller DB. 1995. Quantitative aspects of drug and toxicant-induced astrogliosis. Neurochem Int 26: 115-124.
14. Pasinetti GM. 1998. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J Neurosci Res 54:1-6.
15. Pike CJ, Cummings BJ, Cotman CW. 1995. Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp Neurol 132:172-179.
16. Popovic N, Schubart A, Goetz BD, Zhang SC, Linington C, Duncan ID. 2002. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51:215-223.
17. Ryu JK, Nagai A, Kim J, Lee MC, McLarnon JG, Kim SU. 2003. Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid: in vitro and in vivo studies. Neurobiol Dis 12:121-132.
18. Selkoe DJ. 1999. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A23-31.
19. Stewart WF, Kawas C, Corrada M, Metter EJ. 1997. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632.
20. Tikka TM, Koistinaho JE. 2001. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166:7527-7533.
21. Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E, Esler WP, Maggio JE, Mantyh PW. 1998. Fibrillary beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 18:2161-2173.
22. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.
23. Yankner BA. 1996. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932.
24. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96: 13496-13500.